Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | PGR | P06401 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | PRKDC | P78527 | 1/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | MMP12 | P39900 | 1/20 | 0.30 |
| ▸ | MMP13 | P45452 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18052847 | 0.93 | HSP90AA1 (0.34) | AHRMEN1KMT2AMAPTPGR | |
| SCHEMBL18052806 | 0.89 | MEN1 (0.42) | AHRMEN1KMT2AMAPTPGR | |
| SCHEMBL15895268 | 0.88 | PGR (0.40) | AHRMEN1KMT2AMAPTPGR | |
| SCHEMBL18052855 | 0.84 | PGR (0.30) | PGR | |
| SCHEMBL18052856 | 0.83 | PGR (0.40) | AHRMEN1KMT2AMAPTPGR | |
| SCHEMBL15895274 | 0.82 | MEN1 (0.36) | AHRMEN1KMT2AMAPTPGR | |
| SCHEMBL15895270 | 0.82 | MEN1 (0.36) | AHRMEN1KMT2AMAPTPGR | |
| SCHEMBL18052826 | 0.82 | MAPT (0.43) | AHRMEN1KMT2AMAPTPGR | |
| SCHEMBL18052807 | 0.81 | MAOB (0.36) | AHRMEN1KMT2AMAPTPGR | |
| SCHEMBL18052844 | 0.81 | AHR (0.33) | AHRMEN1KMT2AMAPTPGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10559756-B2 | Materials for electronic devices | MERCK PATENT GMBH (DE) | 2020-02-11 | — | — | US | disclosed |
| US-20160254456-A1 | Materials for Electronic Devices | MERCK PATENT GMBH (DE) | 2016-09-01 | — | — | US | disclosed |
| US-20160254456-A1 | Materials for Electronic Devices | MERCK PATENT GMBH (DE) | 2016-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160254456-A1 | Materials for Electronic Devices | FHIT, TEC, EED | AHR 2367/4885MEN1 674/4885KMT2A 1298/4885 |
| US-10559756-B2 | Materials for electronic devices | TEC, EFNA1, BMI1 | AHR 2351/4885MEN1 234/4885KMT2A 1643/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.